Rheumatic Complications of Immune Checkpoint Inhibitors
- PMID: 33589099
- DOI: 10.1016/j.mcna.2020.09.009
Rheumatic Complications of Immune Checkpoint Inhibitors
Abstract
Immune checkpoint inhibitors activate the immune system to combat cancer. In doing so, however, they can cause immune-related adverse events (irAEs), including rheumatic syndromes, such as inflammatory arthritis, polymyalgia rheumatica, and myositis. This article reviews rheumatic irAEs that may be encountered in the general medicine practice and provides guidance to support prompt recognition, referral, and treatment of these patients.
Keywords: Cancer; Disease-modifying antirheumatic drugs; Immune checkpoint inhibitors; Immune-related adverse events; Myositis; Polymyalgia rheumatica; Rheumatoid arthritis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have no commercial or financial conflicts of interest. N. Ghosh is supported by an NIH grant as a Master’s degree student in Clinical and Translational Investigation at Weill Cornell Medicine: NIH/NCATSUL1-TR-0023849.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical